Helus Pharma (HELP) Stock Price, Quote, News & History | Benzinga

Helus Pharma Inc (HELP) Stock Price, Quote, News & History

HELPNASDAQ

Trade with Public

Trade with Public

$13.63

-0.35-2.54%

At close: Aug 26, 5:00 PM EST

$13.85

0.221.61%

After Hours: 7:32 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$14.19

Close

$13.63

Volume / Avg.

1.56M / 1.53M

Day Range

$13.59 - $14.28

52 Wk Range

3.76 - 14.35

Market Cap

$1.01B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

78

Short Interest

-

Days to Cover

1.38

Recent Cybin Inc. News

Airsculpt Technologies, Barrick Mining And Other Big Stocks Moving Lower In Monday’s Pre-Market Session

Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% after reporting Q2 results in-line with estimates. Other stocks moving lower in pre-market trading include NAMI, BNED, YXT, TENX, MSC, B, VRSK, XFOR, HELP, and SLDB.

Avi Kapoor

Crude Oil Surges 2%; 3M Shares Gain After Q2 Results

US stocks trade higher as Dow Jones gains over 350 points. Tech shares rise by 2% while consumer staples fall. 3M Co. sees 9% jump after strong earnings.

Avi Kapoor

Hasbro, Utz Brands, Park Aerospace And Other Big Stocks Moving Higher On Tuesday

US stocks rise, Nasdaq gains 1%. Hasbro Inc (HAS) up 8.6% on strong Q2 results and raised sales guidance. Other gainers: UTZ, AEHR, PKE, FWRD, HELP, SECZ, DOCN, TRAX, PVLA, COIN.

Avi Kapoor

Abbott Laboratories, AtaiBeckley, ManpowerGroup And Other Big Stocks Moving Higher On Thursday

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, stock jumps 12.1%. Other big gainers include ATAI, MAN, DSGR, CDNA, MAAS, HELP, RHI, SMG, FWRD, UNH, JBHT.

Avi Kapoor

Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7.9% in pre-market trading. Other top gainers include ATPC, TGHL, ATAI, DXST, KAPA, EHGO, HELP, VSA, and CMPS.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-140.79M

Investing Cash Flow (TTM)

-1.46M

Financing Cash Flow (TTM)

190.14M

Free Cash Flow (TTM)

-142.26M

Capital Expenditure (TTM)

-1.46M

Net Change in Cash (TTM)

47.88M

Analyst Trends and Forecast

1

Mar

1

Apr

3

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$976.62M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

4.22

Earnings Yield % (TTM)

-29.03%

Earnings Yield % (FWD)

-20.11%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.31

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$166.37M

Debt to Equity

-

Issuance of Debt (TTM)

-$44.50M

Repayment of Debt (TTM)

-

Key Statistics

Open

$14.19

Close

$13.63

Volume / Avg.

1.56M / 1.53M

Day Range

$13.59 - $14.28

52 Wk Range

3.76 - 14.35

Market Cap

$1.01B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

78

Short Interest

-

Days to Cover

1.38

About

Sector

Health Care

Industry

Pharmaceuticals

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Helus Pharma (HELP) stock?

A

You can purchase shares of Helus Pharma (NASDAQ:HELP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Helus Pharma (HELP) competitors?

A

Other companies in Helus Pharma’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).

Q

What is the forecast, or price target, for Helus Pharma (HELP) stock?

A

Helus Pharma has a consensus price target of $47.50.

Q

What is the current price for Helus Pharma (HELP)?

A

The stock price for Helus Pharma (NASDAQ: HELP) is $13.85 last updated August 26, 2026 at 7:32 PM EDT.

Q

Does Helus Pharma (HELP) pay a dividend?

A

There are no upcoming dividends for Helus Pharma.

Q

When is Helus Pharma (NASDAQ:HELP) reporting earnings?

A

Helus Pharma does not have any upcoming earnings scheduled.

Q

Is Helus Pharma (HELP) going to split?

A

There is no upcoming split for Helus Pharma.

Q

What sector and industry does Helus Pharma (HELP) operate in?

A

Helus Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.